CD8A and neoplasm: The Immunoscore, derived from the densities of CD3+ and CD8+ lymphocytes in the invasive margin and tumour centre, has proven to be a strong prognostic marker, especially in CRC, and could be used alongside traditional TNM-staging to better evaluate patient outcome [16].